Scottish Health Technologies Group

A knowledge broker for Scotland's health networks     

The Scottish Health Technologies Group (SHTG) is an advisory group set up to provide assistance to NHSScotland boards when considering selected health technologies, excluding medicines which will be reviewed by the Scottish Medicines Consortium (SMC).

The remit of the SHTG is to provide advice on the evidence about the clinical and cost effectiveness of existing and new technologies likely to have significant implications for patient care in Scotland. This advice should support the planning and decision making processes in NHS boards. This includes a horizon scanning function to provide early intelligence on health technologies in development.

Share this content

Evidence


Latest SHTG publications

  • What is the clinical effectiveness, cost effectiveness and safety of home health monitoring compared with usual care for patients with moderate to severe chronic obstructive pulmonary disease?
    Evidence note
    Advice Statement
  • What is the clinical effectiveness and cost effectiveness of home health monitoring devices compared with usual care for patients with hypertension?
    Evidence note
    Advice Statement
  • What is the effectiveness, safety and cost-effectiveness of the MitraClip® transcatheter mitral valve repair system in patients with moderate to severe or severe mitral regurgitation who are at high surgical risk or are non-surgical candidates?            
    Evidence note
    Advice Statement
  • Is patient self-monitoring (including self-testing and self-management) of oral anticoagulation therapy safe, efficacious and cost effective?
    Evidence note

    Advice Statement

SHTG meeting dates

  • 28 July 2016
  • 27 October 2016
  • 8 December 2016

All meetings are held in Delta House, Glasgow.